• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis. Modifiable
risk factors including cigarette smoking, dyslipidemia, diabetes, poor diet quality, obesity …

BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Background: Peripheral artery disease (PAD) affects more than 202 million people
worldwide. Several studies have shown that patients with PAD are often undertreated, and …

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events,
but risk factor management is usually suboptimal. This Joint Task Force from the European …

Background An increasing number of patients with a peripheral arterial occlusive disease
were put on statins during the past years. This study assessed whether statin therapy was …

Background: Broadly available digital and mobile health applications (also known as
mHealth) have recently gained increasing attention by the vascular community, but very little …

Background: To determine the adherence to supervised exercise training and underlying
reasons for non-adherence amongst patients with inpatient treatment of symptomatic lower …

Atherosclerosis is a multifactorial, lipoprotein-driven condition that leads to plaque formation
within the arterial tree, leading to subsequent arterial stenosis and thrombosis that accounts …

With an increasing global burden of patients with chronic peripheral artery disease (PAD)
the safe and effective provision of lower limb revascularisation is a growing medical need …